Condition
T-cell Malignancies clinical trials and research
As of November 12, 2026, Find a Trial lists 4 T-cell Malignancies clinical trials that are recruiting, at sites in 2 countries (most in China (3), United States (1)). By phase: Phase 1/2 (3), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest T-cell Malignancies clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| ELA026 for adults with relapsed or refractory T-cell and NK-cell cancers | Phase 1 | New Haven, Connecticut and 5 other locations | Recruiting | Mar 12, 2026 |
| Nanobody CD5 CAR‑T for relapsed or refractory CD5‑positive T‑cell cancers | Phase 1/2 | Beijing, Beijing Municipality and 3 other locations | Recruiting | Jul 17, 2025 |
| CD5 CAR T-cell therapy for relapsed or refractory T-cell malignancies | Phase 1/2 | Beijing, Beijing Municipality and 3 other locations | Recruiting | Mar 19, 2024 |
| CD7 CAR-T therapy for patients with relapsed or refractory T-cell malignancies | Phase 1/2 | Beijing, Beijing Municipality and 3 other locations | Recruiting | Mar 18, 2024 |
All recruiting trials (4)
-
ELA026 for adults with relapsed or refractory T-cell and NK-cell cancers
This Phase 1 trial will test whether ELA026 can help adults with relapsed or refractory T/NK cell cancers who have already received prior therapies.
-
Nanobody CD5 CAR‑T for relapsed or refractory CD5‑positive T‑cell cancers
This will test a CD5-targeted CAR‑T cell treatment using patients' own or donor-derived cells to try to help people with relapsed or refractory CD5+ T‑cell leukemias and lymphomas.
-
CD5 CAR T-cell therapy for relapsed or refractory T-cell malignancies
This study is testing a new CAR T-cell therapy for people with hard-to-treat T-cell cancers to see if it is safe and how well it works.
-
CD7 CAR-T therapy for patients with relapsed or refractory T-cell malignancies
This study is testing a new type of CAR-T therapy for people with T-cell leukemia that hasn't responded to other treatments to see if it can help them feel better.
Related topics
Quick answers
How many T-cell Malignancies clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (3 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 3, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.